Catalyst Wire Dossier Catalyst Wire Dossier

HBV-specific TCR-T cell therapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HBV-specific TCR-T cell therapy, covering 2025-07-17 to 2025-07-17. Get the full timeline:

Most recent: Clinical Trial Update: HBV-Specific TCR-T Cell Therapy Combined With Nucleos(t)Ide Analogues in Chronic Hepatitis B Patients [Phase 1]

See pricing